Astun Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-01-2025
- Paid Up Capital ₹ 0.50 M
as on 04-01-2025
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 9105.61%
(FY 2022)
- Profit 463.86%
(FY 2022)
- Ebitda -437.50%
(FY 2022)
- Net Worth 3.68%
(FY 2022)
- Total Assets -18.35%
(FY 2022)
About Astun Pharma Labs
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Davuluri Bharath and Shaik Ayesha serve as directors at the Company.
- CIN/LLPIN
U24304TG2019PTC133945
- Company No.
133945
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Astun Pharma Labs Private Limited offer?
Astun Pharma Labs Private Limited offers a wide range of products and services, including Industrial Air Conditioner & Devices, Air Damper, Hotel & Commercial Cooking Equipment, Commercial Kitchen Equipments, Material Testing Labs & Services, Environmental Testing Services, Environment Protection & Auditing, Energy Conservation, Cleanroom Equipment & Supplies, Pass Box.
Who are the key members and board of directors at Astun Pharma Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Davuluri Bharath  | Managing Director | 08-Jul-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shaik Ayesha | Director | 11-Nov-2020 | Current |
Financial Performance of Astun Pharma Labs.
Astun Pharma Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 9105.61% increase. The company also saw a substantial improvement in profitability, with a 463.86% increase in profit. The company's net worth moved up by a moderate rise of 3.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astun Pharma Labs?
Unlock access to Astun Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Astun Pharma Labs?
Unlock and access historical data on people associated with Astun Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astun Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astun Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
